Transcription factor plays key role in AML gene regulatory networksNovember 12, 2018Leukemia, Myelodysplasia, Transplantation
Report details financial burden of blood cancersNovember 8, 2018Practice ManagementLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Variant not linked to CLL in Southeast EuropeNovember 7, 2018Leukemia, Myelodysplasia, Transplantation
Venetoclax/HMA combo still safe, effective for elderly with AMLNovember 5, 2018Leukemia, Myelodysplasia, Transplantation
AML relapse after HSCT linked to potentially reversible immune changesNovember 2, 2018Leukemia, Myelodysplasia, Transplantation
Researchers consider R/R ALL drugs in the first-line settingOctober 17, 2018Leukemia, Myelodysplasia, TransplantationImmuno-oncology
Ibrutinib plus obinutuzumab gets priority review in CLL/SLLOctober 17, 2018Leukemia, Myelodysplasia, TransplantationImmuno-oncology
FDA offers guidance on MRD assessment in blood cancer trialsOctober 16, 2018Practice ManagementLeukemia, Myelodysplasia, Transplantation
Genomic profiling predicts outcomes in patients with MPNOctober 10, 2018Leukemia, Myelodysplasia, Transplantation
Some mutation testing can be useful at CLL diagnosisOctober 5, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Novel options for treating hairy cell leukemiaOctober 2, 2018Leukemia, Myelodysplasia, Transplantation
Venetoclax promising in unfit elderly AML patientsOctober 1, 2018Leukemia, Myelodysplasia, Transplantation